文献速递功能神经外科

双侧丘脑底核脑深部电刺激治疗原发性Meige综合征

Bilateral deep brain stimulation of the subthalamic nucleus in primary Meige syndrome.
PubMed 文献 · J Neurosurg · 2017-05-26

该回顾性研究评估了双侧丘脑底核脑深部电刺激对15例药物或肉毒毒素治疗反应不佳的原发性Meige综合征患者的疗效与安全性。14例连续患者末次随访(28.5±16.5个月)时Burke-Fahn-Marsden肌张力障碍评定量表运动亚评分从术前19.3±7.6降至5.5±4.5,平均改善74%(p<0.05);残疾亚评分从15.6±4.9降至6.1±3.5(p<0.05),SF-36评分较基线明显升高;3例患者发生4次不良事件,均无永久后遗症。作者认为这些发现进一步支持丘脑底核刺激作为药物难治性Meige综合征替代治疗的长期疗效与安全性。

要点

  • 14例连续患者末次随访(28.5±16.5个月)运动亚评分从19.3±7.6降至5.5±4.5,平均改善74%(p<0.05)。
  • 残疾亚评分从15.6±4.9降至6.1±3.5(p<0.05),术后SF-36评分较基线明显升高。
  • 3例患者发生4次不良事件,均无永久后遗症。

核心结论

  • 这些发现进一步支持丘脑底核刺激作为药物难治性Meige综合征患者的替代治疗具有长期疗效和安全性。

研究设计与样本

  • 回顾性研究,纳入15例对药物治疗或肉毒毒素注射反应不佳的原发性Meige综合征患者,接受双侧丘脑底核刺激。
  • 采用Burke-Fahn-Marsden肌张力障碍评定量表的运动与残疾亚评分于术前和末次随访时评估肌张力障碍严重程度。
  • 运动量表由一名不知晓患者神经刺激状态的独立评估者根据术前和术后视频资料评估。
  • 生活质量采用医学结局研究36项短式一般健康调查(SF-36)评估。

主要发现

  • 14例连续患者运动亚评分从术前19.3±7.6降至末次随访(28.5±16.5个月)5.5±4.5,平均改善74%(p<0.05)。
  • 残疾亚评分从术前15.6±4.9降至末次随访6.1±3.5(p<0.05)。
  • 术后SF-36评分较基线明显升高。
  • 双侧丘脑底核刺激在刺激后即刻改善患者症状,且所需刺激参数低于原发性Meige综合征苍白球脑深部电刺激所需参数。
  • 3例患者发生4次不良事件,所有事件均缓解且无永久后遗症。

临床怎么用

  • 作者认为丘脑底核刺激可作为药物难治性Meige综合征的替代治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Subthalamic nucleus deep brain stimulation has been shown to be effective in reducing symptoms of primary Meige syndrome. However, assessments of its efficacy and safety have been limited to several case reports and small studies. METHODS The authors performed a retrospective study to assess the efficacy and safety of bilateral subthalamic nucleus stimulation in 15 patients with primary Meige syndrome who responded poorly to medical treatments or botulinum toxin injections. Using the movement and disability subscores of the Burke-Fahn-Marsden Dystonia Rating Scale, the authors evaluated the severity of patients' dystonia and related before surgery and at final follow-up during neurostimulation. The movement scale was assessed based on preoperative and postoperative video documentation by an independent rater who was unaware of each patient's neurostimulation status. Quality of life was assessed with the Medical Outcomes Study 36-Item Short-Form General Health Survey. RESULTS The dystonia movement subscores in 14 consecutive patients improved from 19.3 ± 7.6 (mean ± standard deviation) before surgery to 5.5 ± 4.5 at final follow-up (28.5 ± 16.5 months), with a mean improvement of 74% (p < 0.05). The disability subscore improved from 15.6 ± 4.9 before surgery to 6.1 ± 3.5 at final follow-up (p < 0.05). In addition, the postoperative SF-36 scores increased markedly over those at baseline. The authors also found that bilateral stimulation of the subthalamic nucleus immediately improved patient symptoms after stimulation and required lower stimulation parameters than those needed for pallidal deep brain stimulation for primary Meige syndrome. Four adverse events occurred in 3 patients; all of these events resolved without permanent sequelae. CONCLUSIONS These findings provide further evidence to support the long-term efficacy and safety of subthalamic nucleus stimulation as an alternative treatment for patients with medically intractable Meige syndrome.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zhan S, Sun F, Pan Y, et al. Bilateral deep brain stimulation of the subthalamic nucleus in primary Meige syndrome. J Neurosurg. 2017. PMID: 28548593. doi:10.3171/2016.12.JNS16383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。